These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A wonderful life or diarrhea and dry mouth? Policy issues of direct-to-consumer drug advertising on television. Macias W, Pashupati K, Lewis LS. Health Commun; 2007; 22(3):241-52. PubMed ID: 17967146 [Abstract] [Full Text] [Related]
7. A decade of direct-to-consumer advertising of prescription drugs. Donohue JM, Cevasco M, Rosenthal MB. N Engl J Med; 2007 Aug 16; 357(7):673-81. PubMed ID: 17699817 [Abstract] [Full Text] [Related]
8. Pharmaceutical advertising as a consumer empowerment device. Rubin PH. J Biolaw Bus; 2001 Aug 16; 4(4):59-65. PubMed ID: 12751498 [Abstract] [Full Text] [Related]
10. Do ads really drive pharmaceutical sales? The true effects of DTC advertising remain a mystery. Findlay S. Mark Health Serv; 2002 Aug 16; 22(1):20-5. PubMed ID: 11881540 [Abstract] [Full Text] [Related]
11. Association Between Drug Characteristics and Manufacturer Spending on Direct-to-Consumer Advertising. DiStefano MJ, Markell JM, Doherty CC, Alexander GC, Anderson GF. JAMA; 2023 Feb 07; 329(5):386-392. PubMed ID: 36749334 [Abstract] [Full Text] [Related]
13. Effects of direct-to-consumer advertising of hydroxymethylglutaryl coenzyme a reductase inhibitors on attainment of LDL-C goals. Bradford WD, Kleit AN, Nietert PJ, Ornstein S. Clin Ther; 2006 Dec 07; 28(12):2105-18; discussion 2104. PubMed ID: 17296467 [Abstract] [Full Text] [Related]
14. Comment: the economics of direct-to-consumer advertising of prescription-only drugs: prescribed to improve consumer welfare? Rosenthal M. J Health Serv Res Policy; 2004 Jan 07; 9(1):39-42; discussion 41-2. PubMed ID: 15006239 [No Abstract] [Full Text] [Related]
15. Matching prescription drugs and consumers. The benefits of direct advertising. Masson A, Rubin PH. N Engl J Med; 1985 Aug 22; 313(8):513-5. PubMed ID: 4022085 [No Abstract] [Full Text] [Related]
16. Selling prescription drugs to the consumer: with Vioxx's withdrawal, new questions on a $3.8 billion ad business. Elliott S, Ives N. N Y Times Web; 2004 Oct 12; ():C1, C9. PubMed ID: 15487065 [No Abstract] [Full Text] [Related]